Hospira Blocks Sandoz's Generic Precedex
One of two patents asserted in Hospira Inc's. suit over Sandoz Inc.'s bid for approval of a generic version of the sedative Precedex is valid, and Sandoz is barred from selling...To view the full article, register now.
Already a subscriber? Click here to view full article